Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Charmacy Pharmaceutical Revenue

Charmacy Pharmaceutical had revenue of 2.45B CNY in the half year ending June 30, 2026, with 4.30% growth. This brings the company's revenue in the last twelve months to 4.68B, up 10.24% year-over-year. In the year 2025, Charmacy Pharmaceutical had annual revenue of 4.38B, down -1.15%.

• Revenue (ttm): 4.68B CNY
• Revenue Growth: +10.24%
• P/S Ratio: 0.11
• Revenue / Employee: 5.66M CNY
• Employees: 827
• Market Cap: 593.46M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.38B	-50.83M	-1.15%
Dec 31, 2024	4.44B	31.83M	0.72%
Dec 31, 2023	4.40B	228.35M	5.47%
Dec 31, 2022	4.18B	381.66M	10.06%
Dec 31, 2021	3.79B	-198.09M	-4.96%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error